Breast cancer remains the leading cause of cancer-related mortality among women globally, necessitating accurate diagnosis through histopathological image analysis. However, manual examination of these images is time-consuming and susceptible to inter-observer variability, highlighting the critical need for reliable automated computer-aided diagnostic (CAD) systems. This study was conducted to systematically evaluate and optimize convolutional neural network (CNN) architectures for automated classification of breast cancer histopathology images, with a focus on mitigating overfitting and enhancing diagnostic accuracy through hybrid deep learning methodologies. The principal innovation is the development of a CNN-VGG16 hybrid architecture that strategically integrates pre-trained feature extraction with a customized CNN framework, hypothesized to substantially improve classification accuracy and model generalization. Three model configurations were developed and comparatively analyzed: (1) baseline CNN, (2) CNN with dropout regularization, and (3) hybrid CNN-VGG16 model. Input images underwent preprocessing, including resizing to 150×150 pixels, normalization, and data augmentation. All models were trained with identical hyperparameters: an Adam optimizer with a learning rate of 0.001, a batch size of 32, and 10 epochs. Dropout regularization with a fixed rate of 0.5 was applied to fully-connected layers to mitigate overfitting. Model evaluation was conducted utilizing standard performance metrics. The proposed CNN-VGG16 hybrid model achieved superior performance: accuracy of 85.19%, precision of 87.16%, recall of 92.75%, and F1-score of 88.37%. These metrics represent significant improvements of 4.2% relative to baseline CNN and 3.4% compared to the dropout-regularized variant, indicating substantially enhanced diagnostic capability and reduced false-negative rates. Strategic integration of pre-trained feature extraction with customizable CNN architectures significantly improves generalization and classification performance in histopathological image analysis. Future investigations should incorporate larger heterogeneous datasets, attention mechanisms, and explainable artificial intelligence (XAI) to enhance clinical interpretability and strengthen practitioner confidence in digital pathology systems